| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $49.9M | +0.5% |
| Cost of Revenue | $28.2M | -0.7% |
| Gross Profit | $21.7M | +2.1% |
| R&D Expense | $1.8M | -22.6% |
| SG&A Expense | $42.0M | -21.2% |
| Operating Income | -$20.3M | +36.6% |
| Pre-tax Income | -$29.8M | -0.0% |
| Income Tax | -$68K | -274.4% |
| Net Income | -$29.7M | +0.4% |
| EPS (Basic) | -$0.19 | +0.0% |
| EPS (Diluted) | -$0.19 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.0M | -64.5% |
| Accounts Receivable | $811K | -35.8% |
| Inventory | $18.0M | -4.7% |
| Current Assets | $30.4M | -35.4% |
| Total Assets | $75.3M | -33.6% |
| Current Liabilities | $8.7M | -45.7% |
| Total Liabilities | $77.3M | -10.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.1M | +33.6% |
| Investing Cash Flow | -$412K | +89.1% |
| Financing Cash Flow | -$50K | +65.5% |
| -$2.0M |
| -107.5% |